Repligen Stock Options

RGEN Stock  USD 148.48  3.09  2.04%   
Repligen's latest option contracts expiring on December 19th 2025 are carrying combined implied volatility of 0.62 with a put-to-call open interest ratio of 3.54 over 62 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on December 19th 2025. The total put volume is at 10.0, with calls trading at the volume of 25.0. This yields a 0.4 put-to-call volume ratio.

Open Interest Against December 19th 2025 Option Contracts

The chart above shows Repligen's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Repligen's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Repligen's option, there is no secondary market available for investors to trade.

Repligen Maximum Pain Price Across 2025-12-19 Option Contracts

Max pain occurs when Repligen's market makers reach a net positive position across all Repligen's options at a strike price where option holders stand to lose the most money. By contrast, Repligen's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Repligen

Analyzing Repligen's in-the-money options over time can help investors to take a profitable long position in Repligen regardless of its overall volatility. This is especially true when Repligen's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Repligen's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Repligen's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Repligen lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Repligen's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Repligen contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Repligen Stock moves the wrong way.

Repligen In The Money Call Balance

When Repligen's strike price is surpassing the current stock price, the option contract against Repligen stock is said to be in the money. When it comes to buying Repligen's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Repligen are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Repligen Current Options Market Mood

Repligen's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Repligen Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Repligen's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Repligen's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Repligen contract

Base on the Rule 16, the options market is currently suggesting that Repligen will have an average daily up or down price movement of about 0.0388% per day over the life of the 2025-12-19 option contract. With Repligen trading at USD 148.48, that is roughly USD 0.0575. If you think that the market is fully incorporating Repligen's daily price movement you should consider buying Repligen options at the current volatility level of 0.62%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Repligen options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Repligen calls. Remember, the seller must deliver Repligen stock to the call owner when a call is exercised.

Repligen Option Chain

When Repligen's strike price is surpassing the current stock price, the option contract against Repligen stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Repligen's option chain is a display of a range of information that helps investors for ways to trade options on Repligen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Repligen. It also shows strike prices and maturity days for a Repligen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
RGEN251219C002600007260.00.0 - 2.150.6Out
Call
RGEN251219C0025000012250.00.0 - 1.40.35Out
Call
RGEN251219C002400006240.00.0 - 2.150.36Out
Call
RGEN251219C0023000018230.00.0 - 2.20.25Out
Call
RGEN251219C0022000011220.00.0 - 2.30.85Out
Call
RGEN251219C0021000021210.00.0 - 2.451.74Out
Call
RGEN251219C002000006200.00.0 - 2.71.68Out
Call
RGEN251219C0019500016195.00.3 - 1.852.4Out
Call
RGEN251219C001900003190.00.0 - 3.12.2Out
Call
RGEN251219C001850001185.00.05 - 3.41.35Out
Call
RGEN251219C0018000027180.00.1 - 3.74.4Out
Call
RGEN251219C001750003175.01.0 - 4.63.3Out
Call
RGEN251219C001700002170.01.8 - 5.58.5Out
Call
RGEN251219C00165000303165.02.85 - 6.55.2Out
Call
RGEN251219C00160000139160.04.3 - 7.57.8Out
Call
RGEN251219C0015500068155.05.5 - 9.511.15Out
Call
RGEN251219C00150000173150.08.5 - 10.612.25Out
Call
RGEN251219C0014500025145.011.3 - 14.221.6In
Call
RGEN251219C00140000354140.014.7 - 17.116.7In
Call
RGEN251219C001350006135.018.0 - 20.725.3In
Call
RGEN251219C00130000103130.021.1 - 24.135.97In
Call
RGEN251219C0012500012125.024.8 - 28.834.2In
Call
RGEN251219C001200009120.029.1 - 33.033.99In
Call
RGEN251219C001150002115.033.5 - 37.421.37In
Call
RGEN251219C001050004105.042.8 - 46.742.8In
Call
RGEN251219C001000007100.047.6 - 51.929.0In
Call
RGEN251219C00090000590.057.4 - 61.574.05In
Call
RGEN251219C00080000580.067.5 - 71.380.2In
Call
RGEN251219C00065000165.082.4 - 86.282.4In
Call
RGEN251219C00060000260.087.2 - 91.387.2In
 Put
RGEN251219P002600000260.0109.2 - 113.4109.2In
 Put
RGEN251219P002500000250.099.2 - 103.4131.8In
 Put
RGEN251219P002400000240.089.2 - 93.489.2In
 Put
RGEN251219P002300000230.079.3 - 83.479.3In
 Put
RGEN251219P002200000220.069.2 - 73.469.2In
 Put
RGEN251219P002100000210.059.2 - 63.459.2In
 Put
RGEN251219P002000000200.049.5 - 53.349.5In
 Put
RGEN251219P001950000195.044.6 - 48.444.6In
 Put
RGEN251219P001900001190.039.8 - 43.626.6In
 Put
RGEN251219P001850000185.035.1 - 38.635.1In
 Put
RGEN251219P001650001165.017.9 - 21.318.5In
 Put
RGEN251219P0016000012160.014.7 - 17.615.35In
 Put
RGEN251219P0015500097155.011.4 - 14.49.1In
 Put
RGEN251219P00150000756150.08.9 - 11.89.5In
 Put
RGEN251219P00145000336145.06.6 - 9.56.57Out
 Put
RGEN251219P00140000565140.04.5 - 7.63.55Out
 Put
RGEN251219P001350006135.02.5 - 6.02.2Out
 Put
RGEN251219P001300001027130.01.65 - 4.71.33Out
 Put
RGEN251219P00125000771125.01.0 - 2.352.1Out
 Put
RGEN251219P00120000840120.00.05 - 3.23.5Out
 Put
RGEN251219P0011500073115.00.0 - 2.958.3Out
 Put
RGEN251219P00110000211110.00.0 - 2.32.65Out
 Put
RGEN251219P001050003105.00.0 - 2.24.53Out
 Put
RGEN251219P001000004100.00.0 - 2.155.2Out
 Put
RGEN251219P000950003695.00.0 - 2.150.5Out
 Put
RGEN251219P00090000990.00.0 - 2.151.45Out
 Put
RGEN251219P00085000685.00.0 - 2.150.85Out
 Put
RGEN251219P000800001280.00.0 - 2.151.12Out
 Put
RGEN251219P00075000675.00.0 - 2.151.0Out
 Put
RGEN251219P00070000370.00.0 - 2.151.05Out
 Put
RGEN251219P00065000265.00.0 - 2.150.55Out
 Put
RGEN251219P00060000360.00.0 - 2.152.15Out

Repligen Market Cap Over Time

   Market Cap   
       Timeline  

Repligen Total Stockholder Equity

Total Stockholder Equity

2.07 Billion

At this time, Repligen's Total Stockholder Equity is very stable compared to the past year.

Repligen Corporate Management

Christine GebskiSenior ChromatographyProfile
Kimberly CornwellGeneral CounselProfile
Dianne HeilerSenior SustainabilityProfile
James BylundChief OfficerProfile
Kola OtitojuSenior DevelopmentProfile
Stephen TingleyVP SalesProfile
Jaime HumaraSenior MarketingProfile
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.6
Earnings Share
0.02
Revenue Per Share
12.602
Quarterly Revenue Growth
0.219
Return On Assets
0.0113
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.